Wexford Capital’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q2
Sell
-16,807
Closed -$762K 206
2020
Q1
$762K Buy
+16,807
New +$762K 0.28% 61